Short-term intensive insulin rx lowers glycemic variability in early DM

Short-term intensive insulin therapy (IIT) can improve β-cell function in type 2 diabetes mellitus (T2DM) in association with decreased glycemic variability, according to a study published in the April issue of Diabetes Care. Read more



from DiabetesNews http://ift.tt/1qHw1cs